Physician profile
Miles Jackson
NPI 1336515295
$6,672.47
in general payments reported to CMS, 2019-2025
10 companies · $493 in 2025
The $493 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,910 · 2023: $2,084 · 2024: $185 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,941 · Travel and Lodging: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,941.39 |
| Travel and Lodging | $821.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,845.55 | 2022-2025 | Valiant Captivia, Endurant Iis, Corevalve Evolut R |
| Silk Road Medical, INC. | $1,545.42 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $493.08 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $244.44 | 2022-2025 | Penumbra System, Indigo System |
| W. L. Gore & Associates, INC. | $231.84 | 2022-2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Endologix LLC | $139.70 | 2022 | |
| Bard Peripheral Vascular, INC. | $75.41 | 2022 | |
| Bsn Medical INC | $39.74 | 2022 | |
| Shockwave Medical, INC | $34.33 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Pfizer INC. | $22.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.